logo

For the Inventor, By the Inventor

Hertfordshire, United Kingdom

Pascal Merchiers

This inventor holds 20 USPTO granted patents and 3 published patent applications and 10 EPO patents, primarily in Antibody Modulation. Top assignees: Cancer Research Technology Limited, Tusk Therapeutics Ltd., Black Belt Therapeutics Limited. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pascal Merchiers. Retrieved from https://idiyas.com/inventor/pascal-merchiers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Stevenage, GB (2022 - 2023)
  • Hertfordshire, GB (2020 - 2024)

Company Filing History:

goldMedal12 out of 269 
 
Cancer Research Technology Limited
 patents
silverMedal12 out of 12 
 
Tusk Therapeutics Ltd.
 patents
bronzeMedal8 out of 8 
 
Black Belt Therapeutics Limited
 patents
where one patent can have more than one assignee

Years Active: 2020-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
CD38 Modulating Antibody
Anti-CD25 Antibody
Tumor Specific Cell Depletion
Cancer Treatment
Regulatory T Cells
Human IGG1
Antibody Agents
Therapeutic Applications
20 patents (USPTO):Explore Patents
1. 12698338 - CD38 MODULATING ANTIBODY (2026-08-04),
2. 12343394 - CD38 modulating antibody agents (2025-07-01),
3. 12304964 - CD38 modulating antibody (2025-05-20),
4. 12162949 - CD38 antibody (2024-12-10),
5. 12161717 - CD38 modulating antibody agents (2024-12-10),
6. 11919960 - Anti-CD25 antibody agents (2024-03-05),
7. 11879014 - Method of treating cancer or depleting regulatory T cells in a subject by administering a human IGG1 anti-CD25 antibody (2024-01-23),
8. 11873341 - Anti-CD25 for tumour specific cell depletion (2024-01-16),
9. 11851494 - Anti-CD25 for tumour specific cell depletion (2023-12-26),
10. 11814434 - Anti-CD25 for tumour specific cell depletion (2023-11-14),
11. 11802161 - Anti-CD25 for tumour specific cell depletion (2023-10-31),
12. 11802160 - Anti-CD25 antibody agents (2023-10-31),
13. 11787866 - Anti-CD25 antibody agents (2023-10-17),
14. 11780930 - CD38 modulating antibody (2023-10-10),
15. 11697688 - Anti-CD25 for tumour specific cell depletion (2023-07-11),

Title: Pascal Merchiers - Innovative Inventor from Hertfordshire

Introduction: Pascal Merchiers is a renowned inventor based in Hertfordshire, United Kingdom, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Pascal Merchiers holds several patents in the areas of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his diverse range of interests and expertise.

Career Highlights: With a career spanning over two decades, Pascal Merchiers has worked with leading research institutions and universities to develop cutting-edge technologies that have had a significant impact on society. His commitment to innovation and problem-solving has earned him recognition in the industry.

Collaborations: Pascal Merchiers has collaborated with top companies, banks, and universities worldwide to bring his inventions to life. His ability to work across disciplines and industries has led to the successful implementation of his ideas in real-world applications.

Conclusion: In conclusion, Pascal Merchiers is a visionary inventor whose passion for creating solutions to complex challenges has established him as a key figure in the world of innovation. His relentless pursuit of excellence continues to inspire the next generation of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…